The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identifying the driver histology responsible for the inferior clinicopathologic features associated with plasmacytoid bladder cancer.
 
Elizabeth Davaro
No Relationships to Disclose
 
Facundo Davaro
No Relationships to Disclose
 
Kyle M. Rose
No Relationships to Disclose
 
Prithvi Murthy
No Relationships to Disclose
 
Shreyas U. Naidu
No Relationships to Disclose
 
Lucia P. Camperlengo
No Relationships to Disclose
 
G. Daniel Grass
No Relationships to Disclose
 
Rohit K. Jain
Honoraria - Curio Science; DAVA Oncology; NCCN/Pfizer; OncLive/MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Gilead Sciences; Gilead Sciences; Pfizer; Seattle Genetics/Astellas
Speakers' Bureau - Gilead Sciences; Seagen; Seattle Genetics/Astellas
Research Funding - Bristol Myers Squibb; Gilead Sciences; NCI
 
Logan Zemp
No Relationships to Disclose
 
Alice Yu
No Relationships to Disclose
 
Michael Adam Poch
No Relationships to Disclose
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN; Société Internationale d’Urologie Journal
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Scott Michael Gilbert
No Relationships to Disclose
 
Wade J. Sexton
Consulting or Advisory Role - pacific edge; Urogen pharma
 
Vaibhav Chumbalkar
No Relationships to Disclose
 
Aram Vosoughi
No Relationships to Disclose
 
Roger Li
Stock and Other Ownership Interests - crispr therapeutics; Guardant Health
Consulting or Advisory Role - Arquer Diagnostics; Bristol-Myers Squibb; FerGene; Ferring
Research Funding - CG Oncology
Expert Testimony - CG Oncology
Other Relationship - Predicine